Patent ID: 11969465
Assignee: EMERGENT TRAVEL HEALTH INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A

Claim 3:
4. The isolated polynucleotide of claim 2, wherein the chimeric polypeptide comprises the amino acid sequence selected from the group consisting of SEQ ID NOS: 27-28 wherein residues in parentheses are optional and may be present or absent., A11 (residues in parentheses are optional), (SEQ ID NO: 27)

((MGDKHHHHHHHHHH))KDGSDKGSWEEWNARWDEWENDWNDWREDW

 

QAWRDDWARWRATWMGGRLLSRLERLERRNEELRRLLQLIRHENRMVL

 

QFVRALSMQNAELERRLEELARGMAQVINTNSLSLLTQNNLNRSQSAL

 

GTAIERLSSGLRINSARDDAAGQAIANRFTANIRGLTQASRNANDGIS

 

IAQTTEGALNEINNNLQRVRELAVQSANSTNSQSDLDSIQAEITQRLN

 

EIDRVSGQTQFNGVRVLAQDNTLTIQVGANDGETIDIDLRQINSQTLG

 

LDQLNVQQEYESDDAVVSLLRLLKNAMLTAFFLRNAAAKSFKDILPKK

 

AAASSAYVFSVKKAAAKFVAAWTLKAAAKSTFWPCLLRDSDSDTENPL

 

QRIDAALAQVDALRSDLGAVQNRFNSAITNLGNTVNNLSEARSRIEDS

 

DYATEVSNMSRAQILQQAGTSVLAQANQVPQNVLSLLR, Tox-all (residues in parentheses are optional), (SEQ ID NO: 28)

(MGDDHHHHHHHHHH)

 

WFMGVLVNSLQDITMGSLFFVQDFMIVSISLVQDGLAAAVVAVQDLPQ

 

FATAATRDSPASGRYIQQMLDQRCQEIAAELCQSGLRKMCVPSSRIVA

 

RNAVGITHQNTLQWRCFDTASLLESNQENNGVNCVDDCGHTIPCPGGV

 

HRQNSNHATRHEILSKLVEEGVQRFCSPYQASANKYCNDKFPGTIARR

 

SKGFGNNVEVAWRCYEKASLLYSVYAECASNCGTTWYCPGGRRGTSTE

 

LDKRHYTEEEGIRQAIGSVDSPCSEVEVCLPKDENPPLCLDESGQISR

 

GSWEEWNARWDEWENDWNDWREDWQAWRDDWARWRATWMGGRLLSRLE

 

RLERRNEELRRLLQLIRHENRMVLQFVRALSMQNAELERRLEELARGM

 

AQVINTNSLSLLTQNNLNRSQSALGTAIERLSSGLRINSARDDAAGQA

 

IANRFTANIRGLTQASRNANDGISIAQTTEGALNEINNNLQRVRELAV

 

QSANSTNSQSDLDSIQAEITQRLNEIDRVSGQTQFNGVRVLAQDNTLT

 

IQVGANDGETIDIDLRQINSQTLGLDQLNVQQEYESDDAVVSLLRLLK

 

NAMLTAFFLRNAAAKSFKDILPKKAAASSAYVFSVKKAAAKFVAAWTL

 

KAAAKSTFWPCLLRDSDSDTENPLQRIDAALAQVDALRSDLGAVQNRF

 

NSAITNLGNTVNNLSEARSRIEDSDYATEVSNMSRAQILQQAGTSVLA

 

QANQVPQNVLSLLR.